Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
301
DELISTED
Life Storage, Inc.
LSI
| $7.04M | 0.01% |
111,662
-118,167
| -51% | -$8.44M |
|
302
ACI Worldwide
ACIW
$5.39B
| $6.71M | 0.01% |
278,000
-150,206
| -35% | -$4.79M |
|
303
Nucor
NUE
$62B
| $6.62M | 0.01% |
183,844
+21,487
| +13% | +$954K |
|
304
iShares Global Healthcare ETF
IXJ
$4.17B
| $6.52M | 0.01% |
107,055
+46,409
| +77% | +$3.06M |
|
305
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.49B
| $6.52M | 0.01% |
359,313
-449,783
| -56% | -$9.27M |
|
306
3M
MMM
$94.4B
| $6.47M | 0.01% |
56,653
-33,710
| -37% | -$4.43M |
|
307
Materion
MTRN
$6.04B
| $6.41M | 0.01% |
183,035
-6,244
| -3% | -$310K |
|
|
TPH
308
DELISTED
Tri Pointe Homes
TPH
| $6.35M | 0.01% |
723,760
-274,954
| -28% | -$4.02M |
|
309
Lowe's Companies
LOW
$125B
| $6.22M | 0.01% |
72,243
-44
| -0.1% | -$4.81K |
|
|
B
310
DELISTED
Barnes Group Inc.
B
| $5.98M | 0.01% |
143,000
-56,000
| -28% | -$3.16M |
|
311
Independent Bank
INDB
$4B
| $5.97M | 0.01% |
92,830
+2,537
| +3% | +$181K |
|
312
iShares MSCI ACWI ETF
ACWI
$33.4B
| $5.77M | 0.01% |
92,232
+23,171
| +34% | +$1.72M |
|
313
Ligand Pharmaceuticals
LGND
$5.78B
| $5.7M | 0.01% |
125,589
-13,755
| -10% | -$780K |
|
314
Vertex Pharmaceuticals
VRTX
$125B
| $5.65M | 0.01% |
23,751
+1,398
| +6% | +$321K |
|
315
Neurocrine Biosciences
NBIX
$16.6B
| $5.59M | 0.01% |
64,567
-2,208
| -3% | -$216K |
|
316
LivaNova
LIVN
$4.14B
| $5.56M | 0.01% |
122,949
-55,000
| -31% | -$3.56M |
|
|
EPAY
317
DELISTED
Bottomline Technologies Inc
EPAY
| $5.56M | 0.01% |
151,705
-3,943
| -3% | -$182K |
|
318
Huazhu Hotels Group
HTHT
$13B
| $5.47M | 0.01% |
190,366
-19,778
| -9% | -$673K |
|
319
Carpenter Technology
CRS
$28.4B
| $5.34M | 0.01% |
273,966
-65,086
| -19% | -$2.43M |
|
320
UFP Industries
UFPI
$5.15B
| $5.24M | 0.01% |
141,012
+7,945
| +6% | +$365K |
|
321
Global Payments
GPN
$22.5B
| $5.24M | 0.01% |
36,341
-4,064
| -10% | -$743K |
|
322
TechnipFMC
FTI
$27.1B
| $5.13M | 0.01% |
1,022,065
+56,408
| +6% | +$619K |
|
323
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $5.03M | 0.01% |
195,512
+2,759
| +1% | +$72.8K |
|
|
PCH
324
DELISTED
PotlatchDeltic
PCH
| $4.98M | 0.01% |
158,644
-13,813
| -8% | -$535K |
|
325
Revvity
RVTY
$12.8B
| $4.94M | 0.01% |
65,573
-1,341
| -2% | -$119K |
|
Similar funds
Fisher Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, Fisher Asset Management held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Fisher Asset Management's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Fisher Asset Management's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Fisher Asset Management added most to Mastercard in Q1 2020, an estimated $915M increase.
- Fisher Asset Management's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Fisher Asset Management fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Fisher Asset Management's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Fisher Asset Management opened 84 new positions and closed 116 in Q1 2020.
- Fisher Asset Management's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.